User profiles for Archana Vijay Gaikwad

Dr Archana Vijay Gaikwad ,PhD

University of Tasmania
Verified email at utas.edu.au
Cited by 223

[HTML][HTML] Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?

MS Eapen, W Lu, AV Gaikwad… - European …, 2020 - Eur Respiratory Soc
… Mathew Suji Eapen, Wenying Lu, Archana Vijay Gaikwad, Prem Bhattarai, Collin Chia,
Ashutosh Hardikar, Greg Haug, Sukhwinder Singh Sohal … Conflict of interest: AV Gaikwad …

Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis

AV Gaikwad, MS Eapen, KD McAlinden… - Expert review of …, 2020 - Taylor & Francis
Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible
fibrotic disease associated with respiratory failure. The disease remains idiopathic, but …

Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities

…, MS Eapen, C Chia, AV Gaikwad… - … of Physiology-Lung …, 2022 - journals.physiology.org
Both asthma and COPD are heterogeneous diseases identified by characteristic symptoms
and functional abnormalities, with airway obstruction common in both diseases. Asthma …

Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis

AV Gaikwad, W Lu, S Dey, P Bhattarai… - ERJ open …, 2023 - Eur Respiratory Soc
Background We have previously reported arterial remodelling in patients with idiopathic
pulmonary fibrosis (IPF) and suggested that endothelial-to-mesenchymal transition (EndMT) …

Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new …

MS Eapen, P Sharma, AV Gaikwad, W Lu… - … journal of chronic …, 2019 - Taylor & Francis
COPD is a common and highly destructive disease with huge impacts on people and health
services throughout the world. It is mainly caused by cigarette smoking though …

[HTML][HTML] Endothelial to mesenchymal transition is an active process in smokers and patients with early COPD contributing to pulmonary arterial pathology

…, W Lu, A Hardikar, S Dey, AV Gaikwad… - ERJ Open …, 2024 - Eur Respiratory Soc
Background We have previously reported pulmonary arterial remodelling in smokers and
patients with early COPD, which can be attributed to endothelial to mesenchymal transition (…

Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition

AV Gaikwad, W Lu, S Dey, P Bhattarai… - ERJ Open …, 2022 - Eur Respiratory Soc
Background Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible fibrotic interstitial
lung disease. We performed size-based quantitation of pulmonary arterial remodelling in …

[HTML][HTML] TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving …

AV Gaikwad, MS Eapen, S Dey, P Bhattarai… - Journal of Clinical …, 2024 - mdpi.com
Background: We have previously reported that endothelial-to-mesenchymal transition (EndMT)
is an active process in patients with idiopathic pulmonary fibrosis (IPF) contributing to …

Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension

P Bhattarai, W Lu, AV Gaikwad, S Dey… - ERJ open …, 2022 - Eur Respiratory Soc
Introduction Pulmonary vascular remodelling in chronic obstructive pulmonary disease (COPD)
has detrimental consequences for lung physiology. The aim of our study was to provide …

[HTML][HTML] Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study

…, G Haug, C Chia, J Larby, HC Weber, AV Gaikwad… - Respiratory …, 2023 - Springer
Background Although asthma and chronic obstructive pulmonary disease (COPD) are two
distinct chronic airway inflammatory diseases, they often co-exist in a patient and the …